Literature DB >> 24314621

Influenza vaccination and the end of simplicity.

Thomas Mertens1.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24314621      PMCID： PMC3859907          DOI： 10.3238/arztebl.2013.0791

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN： 1866-0452            Impact factor:   5.594


× No keyword cloud information.
  9 in total

1.  The comparative effectiveness of adjuvanted and unadjuvanted trivalent inactivated influenza vaccine (TIV) in the elderly.

Authors:  P G Van Buynder; S Konrad; J L Van Buynder; E Brodkin; M Krajden; G Ramler; M Bigham
Journal:  Vaccine       Date:  2013-08-06       Impact factor: 3.641

2.  Re: "effectiveness of adjuvanted influenza vaccination in elderly subjects in northern Italy".

Authors:  Danuta M Skowronski; Gaston De Serres; Naveed Z Janjua; Travis S Hottes
Journal:  Am J Epidemiol       Date:  2013-02-22       Impact factor: 4.897

3.  Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.

Authors:  Jacob A Udell; Rami Zawi; Deepak L Bhatt; Maryam Keshtkar-Jahromi; Fiona Gaughran; Arintaya Phrommintikul; Andrzej Ciszewski; Hossein Vakili; Elaine B Hoffman; Michael E Farkouh; Christopher P Cannon
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

Review 4.  Targeted vaccine selection in influenza vaccination.

Authors:  Peter Wutzler; Roland Hardt; Markus Knuf; Klaus Wahle
Journal:  Dtsch Arztebl Int       Date:  2013-11-22       Impact factor: 5.594

Review 5.  Vaccines for preventing influenza in the elderly.

Authors:  Tom Jefferson; Carlo Di Pietrantonj; Lubna A Al-Ansary; Eliana Ferroni; Sarah Thorning; Roger E Thomas
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

6.  Cochrane re-arranged: support for policies to vaccinate elderly people against influenza.

Authors:  Walter E P Beyer; Janet McElhaney; Derek J Smith; Arnold S Monto; Jonathan S Nguyen-Van-Tam; Albert D M E Osterhaus
Journal:  Vaccine       Date:  2013-10-03       Impact factor: 3.641

7.  MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information system.

Authors:  J Puig-Barberà; A Natividad-Sancho; J Calabuig-Pérez; J A Lluch-Rodrigo; E Pastor-Villalba; S Martínez-Úbeda; S Pérez-Vilar; J Díez-Domingo
Journal:  Vaccine       Date:  2013-06-01       Impact factor: 3.641

8.  AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial.

Authors:  Janet E McElhaney; Jiri Beran; Jeanne-Marie Devaster; Meral Esen; Odile Launay; Geert Leroux-Roels; Guillermo M Ruiz-Palacios; Gerrit A van Essen; Adrian Caplanusi; Carine Claeys; Christelle Durand; Xavier Duval; Mohamed El Idrissi; Ann R Falsey; Gregory Feldman; Sharon E Frey; Florence Galtier; Shinn-Jang Hwang; Bruce L Innis; Martina Kovac; Peter Kremsner; Shelly McNeil; Andrzej Nowakowski; Jan Hendrik Richardus; Andrew Trofa; Lidia Oostvogels
Journal:  Lancet Infect Dis       Date:  2013-03-19       Impact factor: 25.071

9.  Interim adjusted estimates of seasonal influenza vaccine effectiveness - United States, February 2013.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-22       Impact factor: 17.586
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.